ArticleJournal of Cancer2022

BET inhibitor JQ1 enhances anti-tumor immunity and synergizes with PD-1 blockade in CRC.

Huijin Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.